{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:53:20Z","timestamp":1770908000805,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010956","name":"SUNY | State University of New York Upstate Medical University","doi-asserted-by":"publisher","award":["Cancer Center Pilot Grant"],"award-info":[{"award-number":["Cancer Center Pilot Grant"]}],"id":[{"id":"10.13039\/100010956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01356-x","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T19:55:11Z","timestamp":1768247711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting and dissociating HIF2\u03b1 from the molecular chaperone Hsp70 triggers apoptosis in kidney cancer"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-8046","authenticated-orcid":false,"given":"Jennifer A.","family":"Heritz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Backe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Pacherille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara J.","family":"Cayaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F.","family":"Basin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britannia","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Sager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Daneshvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn E.","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6737-2832","authenticated-orcid":false,"given":"Mark R.","family":"Woodford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-2775","authenticated-orcid":false,"given":"Dimitra","family":"Bourboulia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Mollapour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2712-4375","authenticated-orcid":false,"given":"Gennady","family":"Bratslavsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"1356_CR1","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","volume":"1","author":"K Kondo","year":"2003","unstructured":"Kondo, K., Kim, W. Y., Lechpammer, M. & Kaelin, W. G. Jr. Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 1, E83 (2003).","journal-title":"PLoS Biol."},{"key":"1356_CR2","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92, 5510\u20135514 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1356_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","volume":"29","author":"A Loboda","year":"2010","unstructured":"Loboda, A., Jozkowicz, A. & Dulak, J. HIF-1 and HIF-2 transcription factors-similar but not identical. Mol. Cells 29, 435\u2013442 (2010).","journal-title":"Mol. Cells"},{"key":"1356_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1073\/pnas.0808092106","volume":"106","author":"TH Scheuermann","year":"2009","unstructured":"Scheuermann, T. H. et al. Artificial ligand binding within the HIF2alpha PAS-B domain of the HIF2 transcription factor. Proc. Natl. Acad. Sci. USA 106, 450\u2013455 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1356_CR5","doi-asserted-by":"crossref","unstructured":"Chen, W. et al. Targeting renal cell carcinoma with a HIF-2 antagonist. Nature, 539, 112\u2013117 (2016).","DOI":"10.1038\/nature19796"},{"key":"1356_CR6","doi-asserted-by":"crossref","unstructured":"Cho, H. et al. On-target efficacy of a HIF2alpha antagonist in preclinical kidney cancer models. Nature, 539, 107\u2013111 (2016).","DOI":"10.1038\/nature19795"},{"key":"1356_CR7","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41591-021-01324-7","volume":"27","author":"TK Choueiri","year":"2021","unstructured":"Choueiri, T. K. et al. Inhibition of hypoxia-inducible factor-2alpha in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis. Nat. Med 27, 802\u2013805 (2021).","journal-title":"Nat. Med"},{"key":"1356_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/1078-0432.CCR-21-3238","volume":"28","author":"TK Choueiri","year":"2022","unstructured":"Choueiri, T. K. et al. From basic science to clinical translation in kidney cancer: a report from the second kidney cancer research summit. Clin. Cancer Res. 28, 831\u2013839 (2022).","journal-title":"Clin. Cancer Res."},{"key":"1356_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nature14883","volume":"524","author":"D Wu","year":"2015","unstructured":"Wu, D., Potluri, N., Lu, J., Kim, Y. & Rastinejad, F. Structural integration in hypoxia-inducible factors. Nature 524, 303\u2013308 (2015).","journal-title":"Nature"},{"key":"1356_CR10","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-16-0473","volume":"76","author":"EM Wallace","year":"2016","unstructured":"Wallace, E. M. et al. A small-molecule antagonist of HIF2alpha is efficacious in preclinical models of renal cell carcinoma. Cancer Res. 76, 5491\u20135500 (2016).","journal-title":"Cancer Res."},{"key":"1356_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271\u2013275 (1999).","journal-title":"Nature"},{"key":"1356_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nrc2502","volume":"8","author":"WG Kaelin Jr.","year":"2008","unstructured":"Kaelin, W. G. Jr. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat. Rev. Cancer 8, 865\u2013873 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"1356_CR13","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1073\/pnas.92.14.6459","volume":"92","author":"DR Duan","year":"1995","unstructured":"Duan, D. R. et al. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc. Natl. Acad. Sci. USA 92, 6459\u20136463 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1356_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm0895-822","volume":"1","author":"O Iliopoulos","year":"1995","unstructured":"Iliopoulos, O., Kibel, A., Gray, S. & Kaelin, W. G. Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1, 822\u2013826 (1995).","journal-title":"Nat. Med."},{"key":"1356_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","volume":"1","author":"K Kondo","year":"2002","unstructured":"Kondo, K., Klco, J., Nakamura, E., Lechpammer, M. & Kaelin, W. G. Jr. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1, 237\u2013246 (2002).","journal-title":"Cancer Cell"},{"key":"1356_CR16","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-22-1054","volume":"28","author":"J Fallah","year":"2022","unstructured":"Fallah, J. et al. FDA approval summary: belzutifan for von hippel-lindau disease-associated tumors. Clin. Cancer Res. 28, 4843\u20134848 (2022).","journal-title":"Clin. Cancer Res."},{"key":"1356_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(23)00276-0","volume":"24","author":"L Albiges","year":"2023","unstructured":"Albiges, L. et al. Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 24, 881\u2013891 (2023).","journal-title":"Lancet Oncol."},{"key":"1356_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"1356_CR19","doi-asserted-by":"publisher","first-page":"W448","DOI":"10.1093\/nar\/gkv306","volume":"43","author":"CM Labbe","year":"2015","unstructured":"Labbe, C. M. et al. MTiOpenScreen: a web server for structure-based virtual screening. Nucleic Acids Res 43, W448\u2013W454 (2015).","journal-title":"Nucleic Acids Res"},{"key":"1356_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12192-008-0060-2","volume":"14","author":"J Hageman","year":"2009","unstructured":"Hageman, J. & Kampinga, H. H. Computational analysis of the human HSPH\/HSPA\/DNAJ family and cloning of a human HSPH\/HSPA\/DNAJ expression library. Cell Stress Chaperones 14, 1\u201321 (2009).","journal-title":"Cell Stress Chaperones"},{"key":"1356_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.molcel.2010.01.005","volume":"37","author":"M Mollapour","year":"2010","unstructured":"Mollapour, M. et al. Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. Mol. Cell 37, 333\u2013343 (2010).","journal-title":"Mol. Cell"},{"key":"1356_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12037","volume":"7","author":"MR Woodford","year":"2016","unstructured":"Woodford, M. R. et al. The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding. Nat. Commun. 7, 12037 (2016).","journal-title":"Nat. Commun."},{"key":"1356_CR23","doi-asserted-by":"publisher","first-page":"D1075","DOI":"10.1093\/nar\/gkt978","volume":"42","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. PubChem BioAssay: 2014 update. Nucleic Acids Res. 42, D1075\u2013D1082 (2014).","journal-title":"Nucleic Acids Res."},{"key":"1356_CR24","doi-asserted-by":"publisher","first-page":"W622","DOI":"10.1093\/nar\/gkq325","volume":"38","author":"MA Miteva","year":"2010","unstructured":"Miteva, M. A., Guyon, F. & Tuffery, P. Frog2: Efficient 3D conformation ensemble generator for small compounds. Nucleic Acids Res. 38, W622\u2013W627 (2010).","journal-title":"Nucleic Acids Res."},{"key":"1356_CR25","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.celrep.2019.07.045","volume":"28","author":"AJ Baker-Williams","year":"2019","unstructured":"Baker-Williams, A. J. et al. Co-chaperones TIMP2 and AHA1 competitively regulate extracellular HSP90:client MMP2 activity and matrix proteolysis. Cell Rep. 28, 1894\u20131906 e1896 (2019).","journal-title":"Cell Rep."},{"key":"1356_CR26","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/sj.gt.3301605","volume":"8","author":"DE Post","year":"2001","unstructured":"Post, D. E. & Van Meir, E. G. Generation of bidirectional hypoxia\/HIF-responsive expression vectors to target gene expression to hypoxic cells. Gene Ther. 8, 1801\u20131807 (2001).","journal-title":"Gene Ther."},{"key":"1356_CR27","unstructured":"DepMap B. DepMap 24Q4 Public. In: Figshare (2024)."},{"key":"1356_CR28","first-page":"1206","volume":"18","author":"XF Ding","year":"2018","unstructured":"Ding, X. F., Zhou, J., Chen, G. & Wu, Y. L. VHL loss predicts response to Aurora kinase A inhibitor in renal cell carcinoma cells. Mol. Med Rep. 18, 1206\u20131210 (2018).","journal-title":"Mol. Med Rep."},{"key":"1356_CR29","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif, F. et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317\u20131320 (1993).","journal-title":"Science"},{"key":"1356_CR30","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/1535-7163.MCT-06-0433","volume":"5","author":"ON Ikediobi","year":"2006","unstructured":"Ikediobi, O. N. et al. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol. Cancer Ther. 5, 2606\u20132612 (2006).","journal-title":"Mol. Cancer Ther."},{"key":"1356_CR31","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.cell.2025.01.046","volume":"188","author":"Q Jiang","year":"2025","unstructured":"Jiang, Q. et al. HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy. Cell 188, 1807\u20131827 e1834 (2025).","journal-title":"Cell"},{"key":"1356_CR32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2120403119","volume":"119","author":"LA Stransky","year":"2022","unstructured":"Stransky, L. A. et al. Sensitivity of VHL mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway. Proc. Natl. Acad. Sci. USA 119, e2120403119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1356_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2012.06.001","volume":"23","author":"C Shen","year":"2013","unstructured":"Shen, C. & Kaelin, W. G. Jr. The VHL\/HIF axis in clear cell renal carcinoma. Semin. Cancer Biol. 23, 18\u201325 (2013).","journal-title":"Semin. Cancer Biol."},{"key":"1356_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.11.1.72","volume":"11","author":"H Tian","year":"1997","unstructured":"Tian, H., McKnight, S. L. & Russell, D. W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11, 72\u201382 (1997).","journal-title":"Genes Dev."},{"key":"1356_CR35","doi-asserted-by":"crossref","unstructured":"Ren, X., Diao, X., Zhuang, J. & Wu, D. Structural basis for the allosteric inhibition of hypoxia-inducible factor (HIF)-2 by belzutifan. Mol. Pharmacol. 102, p240\u2013247 (2022).","DOI":"10.1124\/molpharm.122.000525"},{"key":"1356_CR36","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1074\/jbc.REV118.002810","volume":"294","author":"MP Mayer","year":"2019","unstructured":"Mayer, M. P. & Gierasch, L. M. Recent advances in the structural and mechanistic aspects of Hsp70 molecular chaperones. J. Biol. Chem. 294, 2085\u20132097 (2019).","journal-title":"J. Biol. Chem."},{"key":"1356_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12192-017-0776-y","volume":"22","author":"ER Zuiderweg","year":"2017","unstructured":"Zuiderweg, E. R., Hightower, L. E. & Gestwicki, J. E. The remarkable multivalency of the Hsp70 chaperones. Cell Stress Chaperones 22, 173\u2013189 (2017).","journal-title":"Cell Stress Chaperones"},{"key":"1356_CR38","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1074\/jbc.M109.068577","volume":"285","author":"W Luo","year":"2010","unstructured":"Luo, W. et al. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. J. Biol. Chem. 285, 3651\u20133663 (2010).","journal-title":"J. Biol. Chem."},{"key":"1356_CR39","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Analogs of the allosteric heat shock protein 70 (Hsp70) inhibitor, MKT-077, as anti-cancer agents. ACS Med. Chem. Lett. 4, 1042\u20131047 (2013).","DOI":"10.1021\/ml400204n"},{"key":"1356_CR40","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","volume":"385","author":"E Jonasch","year":"2021","unstructured":"Jonasch, E. et al. Belzutifan for renal cell carcinoma in von Hippel-Lindau disease. N. Engl. J. Med. 385, 2036\u20132046 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1356_CR41","doi-asserted-by":"publisher","first-page":"29936","DOI":"10.1074\/jbc.M204733200","volume":"277","author":"JS Isaacs","year":"2002","unstructured":"Isaacs, J. S. et al. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J. Biol. Chem. 277, 29936\u201329944 (2002).","journal-title":"J. Biol. Chem."},{"key":"1356_CR42","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1074\/jbc.M112.414771","volume":"288","author":"ME Hubbi","year":"2013","unstructured":"Hubbi, M. E. et al. Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation. J. Biol. Chem. 288, 10703\u201310714 (2013).","journal-title":"J. Biol. Chem."},{"key":"1356_CR43","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41417-021-00316-6","volume":"28","author":"X Tang","year":"2021","unstructured":"Tang, X. et al. Heat shock protein-90alpha (Hsp90alpha) stabilizes hypoxia-inducible factor-1alpha (HIF-1alpha) in support of spermatogenesis and tumorigenesis. Cancer Gene Ther. 28, 1058\u20131070 (2021).","journal-title":"Cancer Gene Ther."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01356-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01356-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01356-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:03:20Z","timestamp":1770426200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01356-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01356-x","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}